Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry.
(2022) Gastroenterology — Vol. 162, n° 1, p. 316-319 (2022)
Files
UngaroRCGastroenterology2022.pdf
Open Access - Adobe PDF
- 553.22 KB
Details
- Authors
- Affiliations
Citations
Ungaro, R. C., Brenner, E. J., Agrawal, M., Zhang, X., Kappelman, M. D., & Colombel, J.-F. (2022). Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry. Gastroenterology, 162(1), 316-319. https://doi.org/10.1053/j.gastro.2021.09.011 (Original work published 2022)